The new initiative means that GeroSense will start using this platform for studies on how various factors and interventions move the hands of the step-based aging clock. The first proof-of-concept study will involve a lot of self-reporting: a monthly lifestyle survey in which participants will be asked about their dietary habits as well as about the supplements and medications they are taking. Ad…

Rapamycin is considered by many geroscience researchers to be the “gold standard” of anti-aging drugs; with lifespan improvement typically 15% to 30%, and as high as 37% when combined with another longevity drug “Acarbose”. While these results have been in animals, there are early indications that these benefits may also translate to people. BUT, rapamycin is a serious drug that can have serious…